An initiative launched by the American Heart Association in September aims to improve in-hospital patient care for patients with HFpEF and HFmrEF.

Phenotyping patients can help to identify potential heart failure with preserved ejection fraction (HFpEF) as well as improve patient outcomes.

San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

The American College of Cardiology is launching a new program to educate clinicians on the latest advances, medications and interventions emerging in heart failure (HF) management and treatment.

The proportion of people with heart failure receiving optimal therapy increased significantly with expansion of this initiative within a general cardiology practice.

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...

Among patients with symptomatic chronic heart failure already on guideline-directed medical therapy (GDMT), digitoxin lowered ...